Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schistosome vaccines.

D W Taylor1

  • 1Department of Pathology, University of Cambridge, England.

Experientia
|February 15, 1991
PubMed
Summary
This summary is machine-generated.

Developing effective vaccines is crucial for schistosomiasis control, as current chemotherapy is costly and temporary. Research shows protective immunity exists, targeting parasite surface antigens with immune cells and exploring recombinant and live oral vaccine strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

DECISION MAKING AND PROBLEM SOLVING. CONTRACT NONR 609(20). TECHN REP 9.

Protein alterations in erythrocytes at low temperatures. Bjorksten Research Foundation·2014
Same author

Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies.

Parasite immunology·2012
Same author

A randomized trial of physician training for smoking cessation.

American journal of health promotion : AJHP·2011
Same author

Future prospects and challenges of vaccines against filariasis.

Parasite immunology·2011
Same author

Predicting outcome in acute low-back pain.

Canadian family physician Medecin de famille canadien·2011
Same journal

On the influence of aneurine on the formation of nitrogenic bacterial nodites.

Experientia·2010
Same journal

Around the biochemical activities of the flavobacterium.

Experientia·2010
Same journal

Electron microscopic investigations on cellulose fibers after treatment with ultrasound.

Experientia·2010
Same journal

Reviving scientific life in Hungary.

Experientia·2010
Same journal

A new method for the production of deoxy sugars.

Experientia·2010
Same journal

About the aneine content of the irritated and irritated frog nerves after poisoning with mono-iodoacetic acid.

Experientia·2010
See all related articles

Area of Science:

  • Parasitology
  • Immunology
  • Vaccinology

Background:

  • Current schistosomiasis control relies on expensive and temporary chemotherapy.
  • There is a critical need for a sustainable and effective vaccine against schistosomiasis.
  • Evidence from animal models and human studies indicates the existence of protective immunity.

Purpose of the Study:

  • To explore the potential of vaccines for schistosomiasis control.
  • To identify and target key antigens for vaccine development.
  • To evaluate novel vaccine platforms, including recombinant antigens and live oral vaccines.

Main Methods:

  • Investigating antibody-dependent cell-mediated cytotoxicity (ADCC) mechanisms involving eosinophils and macrophages.
  • Identifying schistosomulum surface antigens as targets for protective immune responses.

Related Experiment Videos

  • Developing and testing vaccines based on recombinant antigens and attenuated Salmonella vectors expressing schistosomular antigens.

    • Main Results:

    • Protective immune responses against schistosomiasis have been demonstrated.
    • Antibody-dependent cell-mediated cytotoxicity mechanisms play a role in parasite destruction.
    • Recombinant antigen vaccines and live oral Salmonella-based vaccines are under development and testing.

    Conclusions:

    • Vaccine development offers a promising alternative to chemotherapy for schistosomiasis control.
    • Targeting schistosomulum surface antigens is a viable strategy for vaccine design.
    • Novel vaccine platforms show potential for inducing protective immunity against schistosomiasis.